Trade Longeveron Inc. - LGVN stock price

0.67
-0.06%
Longeveron Inc., a clinical stage biotechnology company, engages in developing cellular therapies for aging-related and life-threatening conditions. The company''s lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications comprising aging frailty, alzheimer''s disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is headquartered in Miami, Florida.
White Paper Declaration

LGVN price history

Date Close Change Chg% Open Min. Max.
2022-09-30 0.61 -0.01 -1.61 0.62 0.58 0.65
2022-09-30 0.66 -0.05 -7.04 0.71 0.66 0.73
2022-09-30 0.7 0.01 1.45 0.69 0.67 0.75
2022-09-30 0.67 -0.02 -2.90 0.69 0.66 0.69
2022-09-30 0.68 0.01 1.49 0.67 0.67 0.69
2022-09-30 0.68 -0.02 -2.86 0.7 0.67 0.71
2022-09-30 0.69 -0.03 -4.17 0.72 0.69 0.74
2022-09-30 0.71 -0.06 -7.79 0.77 0.71 0.79
2022-09-30 0.79 0.02 2.60 0.77 0.77 0.8
2022-09-30 0.78 -0.04 -4.88 0.82 0.77 0.82
2022-09-30 0.81 -0.01 -1.22 0.82 0.78 0.83

Mobile app

Full trading account functionality: order execution and cancellation, stop-loss and take-profit setup, transaction history, deposits and withdrawals

iOS
4,7
12 127 reviews
Android
4,1
9 795 reviews
Go help.dzengi.com
Dzengi Exchange
Trade BTC & tokenized stocks